IBD 50's GeneDx Inks $51 Million AI-Tied Takeover Deal

IBD 50's GeneDx Inks $51 Million AI-Tied Takeover Deal

IBD 50 stock GeneDx will spend up to $51 million to acquire privately held Fabric Genomics, which is working in AI-powered genomics. The post IBD 50's GeneDx Inks $51 Million AI-Tied Takeover Deal appeared first on Investor's Business Daily.

GeneDx Buys Fabric Genomics to Fuel Clinical Expansion

GeneDx announced it is acquiring Fabric Genomics, a pioneer in AI-powered genomic interpretation. The deal aims to support “GeneDx’s leadership in the next phase of genomic medicine: decentralized testing with centralized intelligence,” according to the press release. The deal is worth potentially just over $50M. “Healthcare is at an inflection point where integrating genomic insights into standard care is becoming essential—both for better clin…

GeneDx To Acquire Fabric Genomics

GeneDx (Nasdaq: WGS), a Stamford, CT-based company which specializes in delivering improved health outcomes through genomic insights, acquired Fabric Genomics, an Oakland, CA-based company which specializes in AI-powered genomic interpretation. Under the terms of the agreement, and subject to the terms and conditions thereof, GeneDx will pay up to an aggregate of $33 million in cash upon closing with total consideration potentially up to an aggr…

GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition

GeneDx has announced its intention to acquire Fabric Genomics, a move that positions it to advance in the field of genomic medicine.The post GeneDx to enhance genomic medicine offerings with Fabric Genomics acquisition appeared first on Medical Device Network.

GeneDx To Acquire Fabric Genomics To Enable AI-Powered, Decentralized Genome Interpretation

GeneDx has announced plans to acquire Fabric Genomics, a company specializing in AI-based genomic interpretation, in a move aimed at expanding the reach and flexibility of clinical genomics. The acquisition, expected to close in Q2 2025, is valued at up to $51 million depending on milestone achievements. The integration brings together GeneDx’s rare disease dataset—built from over 750,000 exomes and genomes—and Fabric’s cloud-native interpretati…

GeneDx to Acquire Fabric Genomics

GeneDx (Nasdaq: WGS), a Stamford, CT-based company which specializes in delivering improved health outcomes through genomic insights, acquired Fabric Genomics, an Oakland, CA-based company which specializes in AI-powered genomic interpretation. Under the terms of the agreement, and subject to the terms and conditions thereof, GeneDx will pay up to an aggregate of $33 million in […] The post GeneDx to Acquire Fabric Genomics appeared first on Fin…